186 related articles for article (PubMed ID: 37310967)
21. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Hepatic Protein Kinase Cβ Expression in Metabolic Adaptation to a Lithogenic Diet.
Huang W; Mehta KD
Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):395-405. PubMed ID: 28210689
[TBL] [Abstract][Full Text] [Related]
23. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
[TBL] [Abstract][Full Text] [Related]
24. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
25. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
27. NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.
Ghosh S; Devereaux MW; Anderson AL; Gehrke S; Reisz JA; D'Alessandro A; Orlicky DJ; Lovell M; El Kasmi KC; Shearn CT; Sokol RJ
Hepatology; 2021 Dec; 74(6):3284-3300. PubMed ID: 34310734
[TBL] [Abstract][Full Text] [Related]
28. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ
J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.
Xie Y; Fung HY; Newberry EP; Kennedy S; Luo J; Crooke RM; Graham MJ; Davidson NO
J Lipid Res; 2014 Mar; 55(3):540-8. PubMed ID: 24474819
[TBL] [Abstract][Full Text] [Related]
30. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
31. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.
Bowden KL; Dubland JA; Chan T; Xu YH; Grabowski GA; Du H; Francis GA
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1191-1201. PubMed ID: 29599133
[TBL] [Abstract][Full Text] [Related]
32. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
[TBL] [Abstract][Full Text] [Related]
33. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter.
Freeman LA; Kennedy A; Wu J; Bark S; Remaley AT; Santamarina-Fojo S; Brewer HB
J Lipid Res; 2004 Jul; 45(7):1197-206. PubMed ID: 15121760
[TBL] [Abstract][Full Text] [Related]
34. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
35. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
[TBL] [Abstract][Full Text] [Related]
36. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
[TBL] [Abstract][Full Text] [Related]
37. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia.
Ratliff EP; Gutierrez A; Davis RA
J Lipid Res; 2006 Jul; 47(7):1513-20. PubMed ID: 16609145
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003
[TBL] [Abstract][Full Text] [Related]
39. ABCG5/ABCG8-independent biliary cholesterol excretion in lactating rats.
Coy DJ; Wooton-Kee CR; Yan B; Sabeva N; Su K; Graf G; Vore M
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G228-35. PubMed ID: 20413720
[TBL] [Abstract][Full Text] [Related]
40. Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.
Jones RD; Repa JJ; Russell DW; Dietschy JM; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G263-74. PubMed ID: 22628034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]